|4Mar 3, 9:07 PM ET

Lawton Alison Frances 4

4 · Kaleido Biosciences, Inc. · Filed Mar 3, 2020

Insider Transaction Report

Form 4
Period: 2020-02-28
LAWTON ALISON FRANCIS
DirectorSee Remarks
Transactions
  • Award

    Restricted Stock Units

    2020-02-28+46,32546,325 total
    Common Stock (46,325 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The restricted stock units shall vest 100% on February 28, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION